FFCP PHASE1:Mm9::chr2:148222757..148222772,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr2:148222757..148222772,-|id=chr2:148222757..148222772,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,1.00e-08,9|ontology_enrichment_disease=DOID:0060100!6.14e-08!3;DOID:4045!6.14e-08!3|ontology_enrichment_disease_v019_2=DOID:0060100,5.11e-24,3;DOID:4045,5.11e-24,3;DOID:0050686,1.41e-12,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.00e-08,9;UBERON:0002036,1.00e-08,9;UBERON:0002385,1.00e-08,9;UBERON:0000486,1.00e-08,9;UBERON:0007503,1.00e-08,9;UBERON:0001015,1.00e-08,9;UBERON:0002329,1.00e-08,9;UBERON:0003082,1.00e-08,9;UBERON:0003059,1.00e-08,9;UBERON:0007282,1.00e-08,9;UBERON:0004290,1.00e-08,9;UBERON:0009618,1.00e-08,9;UBERON:0000383,5.99e-08,10;UBERON:0007524,2.59e-07,11;UBERON:0003077,2.59e-07,11;UBERON:0007285,2.59e-07,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.333109761815663,0,0,0,0,0,0,0.297872853602656,0.783599367416806,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.69650609179052,0,3.14114246384279,105.881667845583,8.19654581950135,2.91306211818692,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.169978429993855,0.559805809294632,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.460325236507177,0.572895513439397,0.515559547031063,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr2:148222757..148222772,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr2:148222757..148222772,- | |||
|description=CAGE_peak_at_chr2:148222757..148222772,- | |||
|id=chr2:148222757..148222772,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.00e-08,9 | |||
|ontology_enrichment_disease=DOID:0060100!6.14e-08!3;DOID:4045!6.14e-08!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,5.11e-24,3;DOID:4045,5.11e-24,3;DOID:0050686,1.41e-12,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.00e-08,9;UBERON:0002036,1.00e-08,9;UBERON:0002385,1.00e-08,9;UBERON:0000486,1.00e-08,9;UBERON:0007503,1.00e-08,9;UBERON:0001015,1.00e-08,9;UBERON:0002329,1.00e-08,9;UBERON:0003082,1.00e-08,9;UBERON:0003059,1.00e-08,9;UBERON:0007282,1.00e-08,9;UBERON:0004290,1.00e-08,9;UBERON:0009618,1.00e-08,9;UBERON:0000383,5.99e-08,10;UBERON:0007524,2.59e-07,11;UBERON:0003077,2.59e-07,11;UBERON:0007285,2.59e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.333109761815663,0,0,0,0,0,0,0.297872853602656,0.783599367416806,0,0,0,0,0,0,0,0,0,0,0,0,0,0,6.69650609179052,0,3.14114246384279,105.881667845583,8.19654581950135,2.91306211818692,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.289864488701678,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11981512450592,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.257347907114715,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.169978429993855,0.559805809294632,0.276399947608848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.460325236507177,0.572895513439397,0.515559547031063,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:148222757..148222772,- | |||
}} |
Latest revision as of 05:26, 4 August 2015
Short description: | p@chr2:148222757..148222772, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:148222757..148222772, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.00e-08 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.00e-08 | 9 |
striated muscle tissue | 1.00e-08 | 9 |
muscle tissue | 1.00e-08 | 9 |
multilaminar epithelium | 1.00e-08 | 9 |
epithelial vesicle | 1.00e-08 | 9 |
musculature | 1.00e-08 | 9 |
somite | 1.00e-08 | 9 |
myotome | 1.00e-08 | 9 |
presomitic mesoderm | 1.00e-08 | 9 |
presumptive segmental plate | 1.00e-08 | 9 |
dermomyotome | 1.00e-08 | 9 |
trunk paraxial mesoderm | 1.00e-08 | 9 |
musculature of body | 5.99e-08 | 10 |
dense mesenchyme tissue | 2.59e-07 | 11 |
paraxial mesoderm | 2.59e-07 | 11 |
presumptive paraxial mesoderm | 2.59e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 5.11e-24 | 3 |
muscle cancer | 5.11e-24 | 3 |
organ system cancer | 1.41e-12 | 6 |